Salomon & Ludwin’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Salomon & Ludwin's TAK Position: Q3 2026 in Review
Salomon & Ludwin increased its Takeda Pharmaceutical (TAK) stake by 35% in Q3 2026, buying an estimated $7.44K and bringing the position to 1,624 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #714.
Salomon & Ludwin first reported a position in TAK in Q2 2025 and has held it in 6 quarters since. The position peaked at $48.6K in Q1 2026. 399 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Salomon & Ludwin held 1,624 shares of Takeda Pharmaceutical worth $29.5K as of Q3 2026.
- Salomon & Ludwin bought 420 Takeda Pharmaceutical shares in Q3 2026, an estimated $7.44K.
- Takeda Pharmaceutical made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #714 holding.
- Salomon & Ludwin first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 6 quarters since.
- Salomon & Ludwin's Takeda Pharmaceutical position peaked at $48.6K in Q1 2026.
- 399 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.